San Diego-primarily based Viking Therapeutics marked alone as a significant competitor during the weight loss drug market in February immediately after revealing promising knowledge from a mid-phase trial of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when specified as a weekly injection As well as … Read More